source
- FDA accuses Baxter leaders of ‘inadequate’ oversight after finding GMP failingsThe recurrence of violations at multiple sites led the FDA to conclude that Baxter management must improve its oversight and control of manufacturing.BioSpace · 25m ago↗ source
- GSK, Ionis win US approval for first-of-its-kind hepatitis B drugHibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s goal of reaching £40 billion in annual revenue by 2031.BioPharma Dive · 1h ago↗ source
- Myriad Genetics to sell off Prenatal Health testing business to LabcorpMyriad Genetics is selling off its Prenatal Health testing biz to Labcorp for $210 million in cash.Fierce Biotech